vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.
Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $213.6M, roughly 1.3× Vital Farms, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 7.6%, a 9.0% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 28.7%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $-32.1M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 20.2%).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".
ALAB vs VITL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $213.6M |
| Net Profit | $45.0M | $16.3M |
| Gross Margin | 75.6% | 35.8% |
| Operating Margin | 24.7% | 10.0% |
| Net Margin | 16.6% | 7.6% |
| Revenue YoY | 91.8% | 28.7% |
| Net Profit YoY | 82.0% | 54.3% |
| EPS (diluted) | $0.25 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $213.6M | ||
| Q3 25 | $230.6M | $198.9M | ||
| Q2 25 | $191.9M | $184.8M | ||
| Q1 25 | $159.4M | $162.2M | ||
| Q4 24 | $141.1M | $166.0M | ||
| Q3 24 | $113.1M | $145.0M | ||
| Q2 24 | $76.8M | $147.4M | ||
| Q1 24 | $65.3M | $147.9M |
| Q4 25 | $45.0M | $16.3M | ||
| Q3 25 | $91.1M | $16.4M | ||
| Q2 25 | $51.2M | $16.6M | ||
| Q1 25 | $31.8M | $16.9M | ||
| Q4 24 | $24.7M | $10.6M | ||
| Q3 24 | $-7.6M | $7.4M | ||
| Q2 24 | $-7.5M | $16.3M | ||
| Q1 24 | $-93.0M | $19.0M |
| Q4 25 | 75.6% | 35.8% | ||
| Q3 25 | 76.2% | 37.7% | ||
| Q2 25 | 75.8% | 38.9% | ||
| Q1 25 | 74.9% | 38.5% | ||
| Q4 24 | 74.0% | 36.1% | ||
| Q3 24 | 77.7% | 36.9% | ||
| Q2 24 | 77.9% | 39.1% | ||
| Q1 24 | 77.4% | 39.8% |
| Q4 25 | 24.7% | 10.0% | ||
| Q3 25 | 24.0% | 10.8% | ||
| Q2 25 | 20.7% | 12.9% | ||
| Q1 25 | 7.1% | 13.4% | ||
| Q4 24 | 0.1% | 7.8% | ||
| Q3 24 | -7.9% | 6.4% | ||
| Q2 24 | -31.7% | 11.6% | ||
| Q1 24 | -127.1% | 16.3% |
| Q4 25 | 16.6% | 7.6% | ||
| Q3 25 | 39.5% | 8.3% | ||
| Q2 25 | 26.7% | 9.0% | ||
| Q1 25 | 20.0% | 10.4% | ||
| Q4 24 | 17.5% | 6.4% | ||
| Q3 24 | -6.7% | 5.1% | ||
| Q2 24 | -9.8% | 11.1% | ||
| Q1 24 | -142.5% | 12.9% |
| Q4 25 | $0.25 | $0.35 | ||
| Q3 25 | $0.50 | $0.36 | ||
| Q2 25 | $0.29 | $0.36 | ||
| Q1 25 | $0.18 | $0.37 | ||
| Q4 24 | $1.23 | $0.23 | ||
| Q3 24 | $-0.05 | $0.16 | ||
| Q2 24 | $-0.05 | $0.36 | ||
| Q1 24 | $-1.77 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $48.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $351.3M |
| Total Assets | $1.5B | $518.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $48.8M | ||
| Q3 25 | $140.4M | $93.8M | ||
| Q2 25 | $162.3M | $108.2M | ||
| Q1 25 | $86.4M | $156.3M | ||
| Q4 24 | $79.6M | $150.6M | ||
| Q3 24 | $126.1M | $149.5M | ||
| Q2 24 | $421.1M | $133.2M | ||
| Q1 24 | $696.1M | $113.8M |
| Q4 25 | $1.4B | $351.3M | ||
| Q3 25 | $1.3B | $331.2M | ||
| Q2 25 | $1.1B | $309.8M | ||
| Q1 25 | $1.0B | $288.9M | ||
| Q4 24 | $964.8M | $269.3M | ||
| Q3 24 | $889.6M | $253.4M | ||
| Q2 24 | $845.3M | $238.4M | ||
| Q1 24 | $808.8M | $213.3M |
| Q4 25 | $1.5B | $518.7M | ||
| Q3 25 | $1.4B | $481.5M | ||
| Q2 25 | $1.3B | $430.8M | ||
| Q1 25 | $1.1B | $376.9M | ||
| Q4 24 | $1.1B | $359.3M | ||
| Q3 24 | $983.1M | $344.7M | ||
| Q2 24 | $915.5M | $320.5M | ||
| Q1 24 | $864.9M | $300.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $5.8M |
| Free Cash FlowOCF − Capex | $76.6M | $-32.1M |
| FCF MarginFCF / Revenue | 28.3% | -15.1% |
| Capex IntensityCapex / Revenue | 6.9% | 17.8% |
| Cash ConversionOCF / Net Profit | 2.12× | 0.35× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $-48.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $5.8M | ||
| Q3 25 | $78.2M | $23.4M | ||
| Q2 25 | $135.4M | $-761.0K | ||
| Q1 25 | $10.5M | $5.3M | ||
| Q4 24 | $39.7M | $14.8M | ||
| Q3 24 | $63.5M | $10.0M | ||
| Q2 24 | $29.8M | $16.1M | ||
| Q1 24 | $3.7M | $23.9M |
| Q4 25 | $76.6M | $-32.1M | ||
| Q3 25 | $65.9M | $-10.6M | ||
| Q2 25 | $133.3M | $-7.6M | ||
| Q1 25 | $6.0M | $2.1M | ||
| Q4 24 | $24.3M | $-3.4M | ||
| Q3 24 | $46.8M | $6.4M | ||
| Q2 24 | $28.5M | $10.5M | ||
| Q1 24 | $228.0K | $22.6M |
| Q4 25 | 28.3% | -15.1% | ||
| Q3 25 | 28.6% | -5.3% | ||
| Q2 25 | 69.5% | -4.1% | ||
| Q1 25 | 3.7% | 1.3% | ||
| Q4 24 | 17.2% | -2.0% | ||
| Q3 24 | 41.4% | 4.4% | ||
| Q2 24 | 37.1% | 7.2% | ||
| Q1 24 | 0.3% | 15.3% |
| Q4 25 | 6.9% | 17.8% | ||
| Q3 25 | 5.3% | 17.1% | ||
| Q2 25 | 1.1% | 3.7% | ||
| Q1 25 | 2.8% | 1.9% | ||
| Q4 24 | 10.9% | 10.9% | ||
| Q3 24 | 14.8% | 2.5% | ||
| Q2 24 | 1.7% | 3.8% | ||
| Q1 24 | 5.2% | 0.9% |
| Q4 25 | 2.12× | 0.35× | ||
| Q3 25 | 0.86× | 1.43× | ||
| Q2 25 | 2.64× | -0.05× | ||
| Q1 25 | 0.33× | 0.31× | ||
| Q4 24 | 1.61× | 1.40× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | — | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALAB
Segment breakdown not available.
VITL
| Eggs And Egg Related Products | $205.8M | 96% |
| Butter And Butter Related Products | $7.7M | 4% |
